Vanderbilt Ingram Cancer Center Archive — Page 30 of 48
-
February 2, 2017
National Cancer Institute’s Lowy details HPV virus research efforts
Douglas Lowy, M.D., acting director of the National Cancer Institute (NCI), warned that worldwide death rates from cervical cancer are expected to increase in low- and middle-income countries during the next 15 years unless steps are taken to prevent the cancer from occurring. Almost all cases of cervical cancer are linked to a viral infection. -
January 26, 2017
Chance to sing for the Pope motivates cancer patient
Cancer patient Sharon Edwards will lift her voice toward what she hopes is a better year when she sings for Pope Francis later this month. -
January 19, 2017
VICC joins cancer genomic data sharing initiative
Vanderbilt-Ingram Cancer Center (VICC) has joined an international consortium of leading cancer centers to share genomic data from patients in an effort to accelerate the pace of cancer research and improve precision medicine. -
January 19, 2017
Metastatic pancreatic cancer ‘reprograms’ for malignancy
Metastatic pancreatic cancer — cancer that has spread from the pancreas to other tissues and is responsible for most patient deaths — changes its metabolism and is “reprogrammed” for optimal malignancy, according to new findings reported Jan. 16 in Nature Genetics. -
January 17, 2017
Vanderbilt-Ingram Cancer Center supports national HPV vaccination efforts
Nearly 39,000 new cancers associated with the human papillomavirus (HPV) will be diagnosed in the United States this year. Although HPV vaccines can prevent the majority of these cancers, vaccination rates remain low across the country. -
January 12, 2017
Morton to help lead blood disorders treatment efforts
Colleen Morton, M.D., has joined Vanderbilt University Medical Center (VUMC) as section chief of Classical Hematology, a specialty also known as “benign hematology” because it covers all blood disorders that are not cancer. -
January 12, 2017
Team’s discovery offers new insight on lung cancer risk
Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic “signature” from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts.